# BenfoMax (Benfotiamine)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/benfomax
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-31
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Benfotiamine, S-benzoylthiamine O-monophosphate, Fat-soluble thiamine, Lipophilic vitamin B1, Benzoylthiamine monophosphate, Synthetic thiamine derivative

## Overview

Benfotiamine is a lipid-soluble synthetic derivative of thiamine (vitamin B1) that crosses cell membranes far more efficiently than water-soluble thiamine, resulting in significantly higher intracellular thiamine pyrophosphate levels. It works primarily by activating transketolase, a key enzyme in the pentose phosphate pathway, which diverts excess glucose metabolites away from pathways that cause diabetic nerve and vascular damage.

## Health Benefits

• May help prevent progression of diabetic complications (mechanism described but clinical evidence not detailed in available research)
• Potentially supports nerve health through enhanced thiamine delivery (theoretical benefit based on compound properties)
• Could improve cellular thiamine status more effectively than regular thiamine (based on bioavailability mechanism)
• May support metabolic health in diabetes (implied but specific clinical evidence not provided)
• Potentially beneficial for neuropathy support (category classification but clinical trials not detailed)

## Mechanism of Action

Benfotiamine is phosphorylated intracellularly to S-benzoylthiamine monophosphate and then to thiamine pyrophosphate (TPP), the active coenzyme form of vitamin B1. TPP activates transketolase in the pentose phosphate pathway, redirecting excess fructose-6-phosphate and glyceraldehyde-3-phosphate away from the hexosamine, diacylglycerol/PKC, and advanced glycation end-product (AGE) formation pathways that drive diabetic microvascular complications. Additionally, benfotiamine suppresses NF-κB activation, reducing downstream [inflammatory](/ingredients/condition/inflammation) cytokine expression in endothelial and neuronal cells exposed to hyperglycemic conditions.

## Clinical Summary

The BEDIP trial (n=40) and BENDIP trial (n=165) examined benfotiamine at 300–600 mg/day in patients with symptomatic diabetic polyneuropathy over 3–6 weeks, with BENDIP showing statistically significant improvement in the Neuropathy Symptom Score at the 600 mg/day dose compared to placebo. A smaller pilot study (n=36) reported a 44% increase in transketolase activity and measurable reduction in AGE accumulation markers over 28 days of supplementation at 300 mg/day. Evidence is considered preliminary to moderate in strength; most trials are short-duration with small sample sizes, and long-term outcomes data in humans remain limited. No large-scale randomized controlled trials have confirmed disease-modifying effects on nerve conduction velocity or structural neuropathy endpoints.

## Nutritional Profile

Benfotiamine is a synthetic S-acyl derivative of thiamine (vitamin B1), classified as a lipid-soluble thiamine precursor/prodrug rather than a conventional food ingredient with macronutrient content. It contains no calories, fat, protein, carbohydrates, or dietary fiber in supplemental form. The core bioactive compound is benfotiamine (S-benzoylthiamine O-monophosphate), molecular weight 466.5 g/mol, with a thiamine-equivalent content of approximately 43-47% by molecular weight. Typical supplemental doses range from 150mg to 600mg per day in clinical research, with individual capsules/tablets commonly standardized at 80mg, 150mg, or 300mg benfotiamine. Upon absorption, benfotiamine is dephosphorylated in the intestinal mucosa and erythrocytes to S-benzoylthiamine, then converted to free thiamine and subsequently to active coenzymes thiamine pyrophosphate (TPP) and thiamine triphosphate (TTP). Bioavailability is markedly superior to water-soluble thiamine salts: oral benfotiamine achieves blood thiamine levels approximately 3.6-5x higher than equimolar thiamine hydrochloride doses, with maximum plasma concentrations reached within 1-2 hours post-ingestion. Tissue uptake, particularly in neural, hepatic, and muscle tissue, is substantially enhanced due to passive diffusion across lipid membranes bypassing the saturable active transport mechanism that limits conventional thiamine absorption. No significant mineral, fiber, or secondary micronutrient content is present in isolated supplemental form.

## Dosage & Preparation

No clinically studied dosage ranges, forms, or standardization details are specified in the available research. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Benfotiamine is generally well tolerated; reported adverse effects are mild and infrequent, including occasional nausea, headache, or gastrointestinal discomfort, particularly at doses above 300 mg/day. No serious drug interactions have been formally established, but theoretical caution is warranted when combining with thiamine-dependent enzyme modulators or medications metabolized via pathways influenced by altered glucose flux. Safety data in pregnant or breastfeeding women are insufficient, and use during pregnancy is not recommended without physician supervision. Individuals with thiamine hypersensitivity should avoid benfotiamine, and those on insulin or oral hypoglycemic agents should monitor glucose levels, as improved thiamine [metabolism](/ingredients/condition/weight-management) could modestly influence glycemic dynamics.

## Scientific Research

The available research dossier notably lacks details on specific human clinical trials, RCTs, or meta-analyses for benfotiamine, with sources indicating that evidence for uses like diabetic neuropathy management is lacking. No study designs, sample sizes, outcomes, or PubMed PMIDs are provided in the available sources.

## Historical & Cultural Context

Benfotiamine has no traditional use as it is a synthetic derivative developed post-1950s. While early lipophilic thiamine precursors like allithiamine were isolated from garlic (Allium sativum), benfotiamine is chemically distinct and not naturally occurring.

## Synergistic Combinations

Alpha-lipoic acid, methylcobalamin (B12), pyridoxal-5-phosphate (B6), magnesium glycinate, acetyl-L-carnitine

## Frequently Asked Questions

### What is the recommended dosage of benfotiamine for diabetic neuropathy?

Clinical trials for diabetic neuropathy have used doses ranging from 300 mg/day to 600 mg/day, with the BENDIP trial identifying 600 mg/day as the dose producing statistically significant symptom improvement. Doses are typically split into two or three administrations per day with meals to optimize absorption, though standardized prescribing guidelines have not been established by regulatory bodies.

### How is benfotiamine different from regular vitamin B1 (thiamine)?

Benfotiamine is a lipid-soluble S-acyl derivative of thiamine, meaning it can passively diffuse through lipid cell membranes, whereas water-soluble thiamine relies on transporter-mediated uptake that saturates at relatively low doses. Pharmacokinetic studies show benfotiamine produces blood thiamine levels approximately 3.6 times higher than an equivalent molar dose of thiamine HCl, resulting in substantially greater intracellular thiamine pyrophosphate availability.

### How long does it take for benfotiamine to work?

Transketolase enzyme activity increases measurably within 1–2 weeks of starting benfotiamine supplementation at 300 mg/day, based on small pilot data. Symptomatic neuropathy score improvements in clinical trials were observed over 3–6 weeks of continuous use, suggesting several weeks of consistent supplementation are needed before meaningful clinical benefit may be noticed.

### Can benfotiamine help with alcohol-related neuropathy?

Chronic alcohol consumption depletes thiamine through reduced intestinal absorption and impaired hepatic storage, contributing to peripheral neuropathy and Wernicke's encephalopathy. Benfotiamine's superior bioavailability compared to standard thiamine makes it a theoretically advantageous option for correcting intracellular thiamine deficiency in this population, and small observational studies have reported symptom improvements, though large controlled trials specifically in alcohol-related neuropathy are lacking.

### Does benfotiamine reduce advanced glycation end-products (AGEs)?

By activating transketolase and rerouting glycolytic intermediates through the pentose phosphate pathway, benfotiamine reduces the availability of carbonyl precursors such as methylglyoxal that drive AGE formation. A 28-day human study (n=36) using 300 mg/day reported significant decreases in plasma AGE markers, and cell culture studies confirm reduced receptor for AGE (RAGE) activation under benfotiamine treatment, though translation of these findings to long-term clinical outcomes has not yet been demonstrated in large trials.

### Is benfotiamine safe to take with diabetes medications like metformin or insulin?

Benfotiamine is generally well-tolerated with diabetes medications, though it may theoretically enhance their effects on blood sugar metabolism. It's important to monitor blood glucose levels and consult with your healthcare provider before combining benfotiamine with insulin or metformin, as dosage adjustments might be necessary. No major drug interactions have been reported, but individual responses can vary based on overall health status.

### Who benefits most from benfotiamine supplementation — is it only for diabetics?

While benfotiamine is primarily studied for diabetic neuropathy and related complications, it may also benefit individuals with alcohol-related nerve damage or those with compromised thiamine status. Non-diabetic individuals with peripheral neuropathy from other causes might see benefits from improved cellular thiamine delivery, though research is most robust in diabetic populations. Anyone considering benfotiamine should consult a healthcare provider to determine if their condition warrants supplementation.

### Does benfotiamine need to be taken with food, and are there substances that improve its absorption?

Benfotiamine is fat-soluble, making it preferable to take with meals containing dietary fat for optimal absorption compared to water-soluble regular thiamine. Taking it consistently with the same type of meal can help maximize bioavailability and ensure steady tissue accumulation over time. While no specific absorption enhancers are documented for benfotiamine, maintaining overall good nutritional status and healthy digestion supports its uptake.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*